Trial intelligence / Profile preview

Tamsulosin post-SWL for renal stones

NCT05032287Completed

Sponsor
Mansoura University
Start
Sep 2019
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial in nephrolithiasis comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Stone free rate at 3 months. Started Sep 2019; status: completed.

02

Drugs

tamsulosin
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on NCT05032287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05032287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call